GENE ONLINE|News &
Opinion
Blog

Editors' Picks
Trending Microsoftlayoffs
Microsoft Layoffs 2025: Tech Giant Cuts 6,000+ Jobs to Advance AI and Streamline Operations
2025-05-14
Industry USAInvestment Summit
SelectUSA Summit 2025: Taiwan, Tunisia, Vietnam, Qatar Supercharge U.S. Investment Surge
2025-05-14
Trending Dietlongevity
The Buffett Paradox: Cola, Happiness, and a Biotech Longevity Enigma
2025-05-11
Industry CEO resigns
UnitedHealth CEO Steps Down, Hemsley Returns as Stock Plummets Amid Industry Crisis and Trump’s Executive Order
UnitedHealth Group, a titan in the health insurance industry, announced a major leadership shakeup on Tuesday, May 13, 2025. Andrew Witty, the company’s CEO, resigned …

Home Read More »

2025-05-14
In-Depth ADC
What Are ADCs? Understanding Their Structure and Cancer-Killing Mechanism
2025-05-13
Special
ASGCT 2025 Cell and Gene Therapy
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
In a study published on May 15 in The New England Journal of Medicine and presented at the American Society of Gene and Cell Therapy …

CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant Read More »

2025-05-16
In-Depth ADC
What Are ADCs? Understanding Their Structure and Cancer-Killing Mechanism
As cancer therapies continue to evolve, antibody-drug conjugates (ADCs) are emerging as a new generation of targeted anti-cancer drugs. By combining monoclonal antibodies, linkers, and …

What Are ADCs? Understanding Their Structure and Cancer-Killing Mechanism Read More »

2025-05-13
Interviews Extracellular Vesicle
A Closer Look at EV-Based Therapeutics: Purification, Scalability, and GMP Compatibility
Dr. Yu Fujita is spearheading a transformative approach to treating lung diseases through extracellular vesicle-based therapeutics, a novel modality poised to redefine therapeutic strategies for …

A Closer Look at EV-Based Therapeutics: Purification, Scalability, and GMP Compatibility Read More »

2025-05-06
LATEST
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-16
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15
Tribal Leaders Warn Senators: Federal Health Funding Cuts Threaten Native American Health.
2025-05-14
Health Secretary Kennedy Retracts Parts of Agency Reorganization Plan During Combative Congressional Hearing
2025-05-14
READ MORE
Deals
Funding
Special
Sen-Jam’s First-in-Class FDA-Regulated Hangover Cure Enters Phase 2 Trials
2024-11-20
VerImmune Completes $4.5 Million First Closing of Pre-Series A Financing, Strengthens Board with Two Accomplished Biotechnology Executives
2024-09-22
$115M Series A Boosts Myricx Bio’s ADC Development with Lilly and Novo Support
2024-07-11
IPO
IPO Ascentage Pharma
China’s Ascentage Snatches First Biotech IPO Price of 2025, Raking in $126M
2025-01-24
CNS Drug-Maker Reviva Announces $18M Public Offering of Common Stock and Warrants to Fund R&D
2024-12-17
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
M&A
Biopharma Documentary Astellas PharmaRx
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Bristol Myers Squibb Acquires Cancer Cell Therapy Partner 2seventy Bio in $286M Deal
2025-03-12
The Stargate Project: A $500 Billion Initiative that Will Bring Tech Giants to the AI Table
2025-01-24
Ranking & Reports
Ranking & Reports
Industry Pharma layoffs
Layoffs in Biotech and Pharma: A March 2025 Snapshot by Therapeutic and Technology Focus
2025-04-03
2024 EU Industrial R&D Investment Scoreboard Highlights 9.8% Increase in R&D Spending
2024-12-30
Global Trade Wars and Innovation Shake Up the Life Sciences Industry
2024-11-06
Categories
Interviews
Interviews medtechIndustry
Climbing the MedTech Mountain: How Startups can Tackle Clinical, Payer, and Exit Peaks
2025-05-06
A Closer Look at EV-Based Therapeutics: Purification, Scalability, and GMP Compatibility
2025-05-06
Rewriting the Rules of AML Therapy: How SENTI-202 Strikes a Critical Balance in CAR-NK Cell Treatment
2025-05-05
Asia-Pacific
Conference
Taiwan’s BPIPO and DCB Join Japan’s LINK-J and FIRM for First Regenerative Medicine Investment Forum in Tokyo
2025-04-29
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Inside the Exosome Boom: Global Experts Talk Industry Trends, Roadblocks, and What’s Next
2025-04-16
Trials & Approvals
Trials & Approvals Alzheimer's Drug
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
2025-04-15
Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part I
2025-03-31
Double Win With FDA’s Green Light Towards Two New Denosumab Biosimilars
2025-03-05
China
China biotech industry
China’s Biotech Industry Is Having Its Moonshot Moment
2025-04-14
Chinese Researchers Decode Autoimmune Mechanisms of Myasthenia Gravis
2025-04-11
China Blocks Illumina’s Sequencers as U.S. Tariffs Double–Trade War Fallout Intensifies
2025-03-06
Startups
Interviews medtechIndustry
Climbing the MedTech Mountain: How Startups can Tackle Clinical, Payer, and Exit Peaks
2025-05-06
Innovation Alone Doesn’t Guarantee Market Success – An Interview with UC Berkeley’s Darren Cooke
2025-02-24
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Manufacturing
Trending R&D investment
Bristol Myers Squibb Bets Big on America with $40 Billion Investment Plan
2025-05-07
Merck Launches $1 Billion Vaccine Facility in North Carolina, Boosting U.S. Manufacturing and Job Creation
2025-03-13
BioNTech’s Bold Move: Rwanda’s New mRNA Vaccine Factory Set to Boost African Healthcare
2024-11-06
Licensing
Licensing FDA
FDA in Review: What’s Next for Biosimilars, Generic Drugs, and the Orange Book?
2025-01-27
Drug Promotion, Nonprescription Pathways, and Advanced Manufacturing: FDA’s Key Focus Areas in 2024 and What’s Next for 2025
2025-01-23
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
R&D
ASGCT 2025 ASGCT 2025
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
Bristol Myers Squibb Bets Big on America with $40 Billion Investment Plan
2025-05-07
Stem Cell Transplants Improve Movement in 2 Paralyzed Patients
2025-05-07
Technology
Trending Microsoftlayoffs
Microsoft Layoffs 2025: Tech Giant Cuts 6,000+ Jobs to Advance AI and Streamline Operations
2025-05-14
Stem Cell Transplants Improve Movement in 2 Paralyzed Patients
2025-05-07
Trump Moves to Slam Tariffs on Pharma and Semiconductors Over National Security Fears
2025-04-15
EVENT
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top